{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-146806","form_type":"8-K/A","ticker":"TBPH","cik":"0001583107","company_name":"Theravance Biopharma, Inc.","filed_at":"2021-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.146962+00:00","generated_at":"2026-06-28T03:31:25.703749+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"Theravance Biopharma enters consulting agreement with departing SVP; equity awards to vest","bullets":["Vijay Sabesan, SVP Technical Operations, left effective Nov 30, 2021 as previously reported.","On Nov 30, 2021, Company and Sabesan entered a consulting agreement to facilitate transition.","Certain outstanding equity awards will vest under the consulting agreement; no dollar amount disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-146806","json":"https://secwatch.observer/filing/0001104659-21-146806.json","markdown":"https://secwatch.observer/filing/0001104659-21-146806.md","text":"https://secwatch.observer/filing/0001104659-21-146806.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583107/000110465921146806/0001104659-21-146806-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583107/000110465921146806/tm2134621d1_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T03:31:25.703749+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"28f0ea79f8","claim":"Vijay Sabesan departed as other_named_officer at Theravance Biopharma, Inc..","evidence_excerpt":"On November 30, 2021, the Company and Mr. Sabesan entered into a consulting agreement to facilitate the transition of activities following Mr. Sabesan’s departure, pursuant to which certain outstanding equity awards will vest.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1583107/000110465921146806/0001104659-21-146806-index.htm","confidence":0.6,"family_label":"Executive change","details":[{"label":"Action","value":"departed"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}